| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access and unmet needs to multiple sclerosis care in a cohort of Argentinean patients
|
Carnero Contentti, Edgar
|
|
2019
|
33 |
C |
p. 88-93
|
artikel
|
| 2 |
B cell depletion and pregnancy: Review and applications for MS treatment
|
Shah, Suma
|
|
2019
|
33 |
C |
p. 153-157
|
artikel
|
| 3 |
Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis
|
Dalla Costa, Gloria
|
|
2019
|
33 |
C |
p. 75-77
|
artikel
|
| 4 |
Complete sequence analysis of human toll-like receptor 3 gene in natural killer cells of multiple sclerosis patients
|
Deeba, Elie
|
|
2019
|
33 |
C |
p. 100-106
|
artikel
|
| 5 |
Editorial on: Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder
|
Pardo, Santiago
|
|
2019
|
33 |
C |
p. A1-A2
|
artikel
|
| 6 |
Efficacy and tolerability of azathioprine for neuromyelitis optica spectrum disorder: A systematic review and meta-analysis
|
Espiritu, Adrian I.
|
|
2019
|
33 |
C |
p. 22-32
|
artikel
|
| 7 |
Five year iron changes in relapsing-remitting multiple sclerosis deep gray matter compared to healthy controls
|
Elkady, Ahmed M.
|
|
2019
|
33 |
C |
p. 107-115
|
artikel
|
| 8 |
Gene and environment interplay in cognition: Evidence from twin and molecular studies, future directions and suggestions for effective candidate gene x environment (cGxE) research
|
Hasan, Anam
|
|
2019
|
33 |
C |
p. 121-130
|
artikel
|
| 9 |
Higher satisfaction and adherence with glatiramer acetate 40 mg/mL TIW vs 20 mg/mL QD in RRMS
|
Cutter, Gary
|
|
2019
|
33 |
C |
p. 13-21
|
artikel
|
| 10 |
Illegal cannabis use is common among Danes with multiple sclerosis
|
Gustavsen, S.
|
|
2019
|
33 |
C |
p. 5-12
|
artikel
|
| 11 |
Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort study
|
Boesen, Magnus S.
|
|
2019
|
33 |
C |
p. 162-167
|
artikel
|
| 12 |
Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab
|
Dekker, I.
|
|
2019
|
33 |
C |
p. 82-87
|
artikel
|
| 13 |
Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study★★
|
Miller, Aaron E.
|
|
2019
|
33 |
C |
p. 131-138
|
artikel
|
| 14 |
MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing?
|
Breza, Marianthi
|
|
2019
|
33 |
C |
p. 67-69
|
artikel
|
| 15 |
Multiple sclerosis national registry system in Iran: Validity and reliability of a minimum data set
|
Shahin, Sarvenaz
|
|
2019
|
33 |
C |
p. 158-161
|
artikel
|
| 16 |
Multiple sclerosis prevalence and incidence in San Vicente del Raspeig, Spain
|
Perez-Carmona, Natalia
|
|
2019
|
33 |
C |
p. 78-81
|
artikel
|
| 17 |
Neural mechanisms of perceptual decision-making and their link to neuropsychiatric symptoms in multiple sclerosis
|
Weygandt, Martin
|
|
2019
|
33 |
C |
p. 139-145
|
artikel
|
| 18 |
Neurodevelopmental retardation in a baby born to a multiple sclerosis patient being treated with fingolimod
|
Cheraghmakani, Hamed
|
|
2019
|
33 |
C |
p. 116-120
|
artikel
|
| 19 |
Neuromyelitis optica testing and treatment: Availability and affordability in 60 countries
|
Holroyd, Kathryn
|
|
2019
|
33 |
C |
p. 44-50
|
artikel
|
| 20 |
Profile of Polish patients with primary progressive multiple sclerosis
|
Brola, Waldemar
|
|
2019
|
33 |
C |
p. 33-38
|
artikel
|
| 21 |
Review: Patient-reported outcomes in multiple sclerosis care
|
D'Amico, Emanuele
|
|
2019
|
33 |
C |
p. 61-66
|
artikel
|
| 22 |
Subclinical cochlear dysfunction in newly diagnosed relapsing-remitting multiple sclerosis
|
Di Mauro, Roberta
|
|
2019
|
33 |
C |
p. 55-60
|
artikel
|
| 23 |
Susac Syndrome: Clinical characteristics, diagnostic findings and treatment in 19 cases
|
Zengin Karahan, S.
|
|
2019
|
33 |
C |
p. 94-99
|
artikel
|
| 24 |
Susceptibility-weighted imaging in the differential diagnosis of autoimmune central nervous system vasculitis and multiple sclerosis
|
Huang, Xuehong
|
|
2019
|
33 |
C |
p. 70-74
|
artikel
|
| 25 |
Switching for convenience from first-line injectable treatments to oral treatments in multiple sclerosis: Data from a retrospective cohort study
|
Buard, Géraldine
|
|
2019
|
33 |
C |
p. 39-43
|
artikel
|
| 26 |
The clinical spectrum of anti-MOG associated acquired demyelinating disorders: Three case-reports
|
Bellinvia, A.
|
|
2019
|
33 |
C |
p. 51-54
|
artikel
|
| 27 |
The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study
|
Curti, Erica
|
|
2019
|
33 |
C |
p. 146-152
|
artikel
|
| 28 |
The 20-year history: Change of multiple sclerosis patient profile over 20 years
|
Ozakbas, Serkan
|
|
2019
|
33 |
C |
p. 1-4
|
artikel
|
Tijdschrift beschrijving